February 21, 2012 — Theragenics Corp.,a medical device company serving the surgical products and prostate cancer treatment markets, announced that it has purchased Core Oncology’s prostate brachytherapy customer base. The asset acquisition was effective on Feb. 17, 2012. The total purchase price is structured as an “earn-out” equal to one times the actual revenue generated from the acquired customers over the twelve-month period beginning September 2012 and ending August 2013 in excess of a $2.5 million threshold amount. Theragenics paid $3.8 million in cash at closing as prepayment of a portion of the earn-out, and will make quarterly earn-out payments thereafter. The company expects to fund the quarterly earn-out payments from operating cash flow and existing cash balances.

“The Core transaction and additional iodine business demonstrates our continuing commitment to this treatment, the physicians and the patients who depend on it,” said M. Christine Jacobs, chairman and CEO of Theragenics Corporation. “The Core customers are in good hands.”

Travis Gay, CEO of Core Oncology, said, “Theragenics has been recognized as a leader and has been a valued partner of Core’s. I am confident that Theragenics will continue the outstanding quality and service to which the Core customers and patients they serve have grown accustomed.”

For more information: www.theragenics.com

Related Content

News | PET Imaging

October 19, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time October 19, 2021
arrow
News | Prostate Cancer

September 24, 2021 — Scientists have identified two subtypes of metastatic prostate cancer that respond differently to ...

Time September 24, 2021
arrow
News | Digital Pathology

September 22, 2021 — The U.S. Food and Drug Administration authorized marketing of software to assist medical ...

Time September 22, 2021
arrow
News | Radiopharmaceuticals and Tracers

September 17, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time September 17, 2021
arrow
News | PET Imaging

September 13, 2021 — Lantheus Holdings, Inc. and RefleXion Medical, Inc., today announced a development and ...

Time September 13, 2021
arrow
News | Brachytherapy Systems

August 31, 2021 — iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy ...

Time August 31, 2021
arrow
News | Prostate Cancer

August 13, 2021 — Researchers at Karolinska Institutet in Sweden recently reported that magnetic resonance imaging (MRI) ...

Time August 13, 2021
arrow
News | Nuclear Imaging

August 4, 2021 — The Council on Radionuclides and Radiopharmaceuticals, Inc. (CORAR), along with physicians and patient ...

Time August 04, 2021
arrow
News | Prostate Cancer

July 19, 2021 — Prostate cancer is the most diagnosed cancer and a leading cause of death by cancer in Australian men ...

Time July 19, 2021
arrow
News | Prostate Cancer

July 12, 2021 — Most countries have not introduced nationwide prostate cancer screening, as current methods result in ...

Time July 12, 2021
arrow
Subscribe Now